Aimei Health Technology AFJK
- Market cap
- $38.2M
- Revenue, 12 months
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| −$153.6K | −$309.1K | −$200K | −$402K | −$413.4K+169% | −$41.6K−87% | −$130.2K−35% | −$250.6K−38% | −$62K−85% | −$192.3K+362% | |
| Net income | $755.5K | $609.1K | $743.5K | $444.1K | $184.7K−76% | $425K−30% | $352K−53% | $98.1K−78% | $45.4K−75% | −$83.1K |
| $0.08 | $0.07 | $0.08 | $0.21 | $0.03−63% | $0.07+0% | $0.06−25% | $0.05−76% | $0.01−67% | −$0.03 | |
| 2.1M | 2.1M | 2.1M | 2.1M | 2.1M+0% | 2.1M+0% | 2.1M+0% | 2.1M+0% | 2.1M+0% | 2.1M+0% |
EPS, diluted: Q4 FY24 and Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY24 and Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial Services nearest Aimei Health Technology's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| AFJKAimei Health Technology | $38.2M | n/m | 78.5× | n/m | n/m | n/m | |
| MBBCMarathon Bancorp | $44.2M | 21.9× | 33.5× | n/m | +33% | 19.8% | |
| GROWU S Global Investors | $32.3M | 10.9× | 18.7× | 3.1× | +21% | 29.8% | |
| TCBSTexas Community Bancshares | $49.5M | 14.2× | 22.8× | n/m | +14% | 19.1% | |
| ATCHAtlasClear | $24M | 15.8× | 17.5× | 1.2× | +85% | 9.8% | |
| RSSSResearch Solutions | $66.2M | 21.8× | 22.2× | 1.4× | −2% | 5.8% | |
| CLSTCatalyst Bancorp | $68.1M | 31.3× | 30.3× | n/m | −2% | 18.0% | |
| VIPVulcan Infrastructure & Power | $19.6M | 17.9× | 24.4× | 0.4× | −14% | 1.0% | |
| UBCPUnited Bancorp | $78.7M | 9.9× | 11.1× | n/m | n/m | n/m | |
| BCGBinah Capital | $18.2M | 6.7× | 20.8× | 0.1× | +8% | 2.2% | |
| HNNAHennessy Advisors | $80.5M | 9.7× | 9.2× | 2.4× | −7% | 24.8% | |
| Peer median | $46.8M | 15.0× | 21.5× | 1.3× | +8% | 18.0% |
More on Aimei Health Technology
Each number over time
Its groups
About
- Industry
- Shell Companies
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .